Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer

Neoplasma

Volumn 51, Issue 4, 2004, Pages 275-284

  Plevova P ^a,b   Krepelova A ^c   Papezova M ^c   Sedlakova E ^a   Curik R ^b   Foretova L ^d   Navratilova M ^d   Novotny J ^c   Zapletalova J ^a   Palas, J ^e   Nieslanik, J ^f   Horacek J ^g   Dvorackova, J ^h   Kolar Z ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^e Department of Pathology   (Czech Republic)

^f Municipal Hospital Ostrava Fifejdy   (Czech Republic)

^g Laboratory of Cytology   (Czech Republic)

^h Laboratory of Cytobiopsy   (Czech Republic)

Author keywords

Colon cancer hereditary nonpolyposis; HMLH1 gene mutations; HMLH1 hMSH2 protein detection; HMSH2 gene mutations; Microsatellite instability

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2;

COLON CANCER; DYSPLASIA; FAMILIAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION; PROTEIN EXPRESSION; REVIEW;

EID: 3142682227     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. AALTONEN LA, PELTOMAKI P, MECKLIN JP, JARVINEN H, JASS JR et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994; 54: 1645-1648.
2. BELLACOSA A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 2001; 8: 1076-1092.
3. BELLACOSA A, GENUARDI M, ANTI M, VIEL A, PONZ DE LEON M. Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996; 62: 353-364.
4. BERENDS MJ, HOLLEMA H, WU Y, VAN DER SLUIS T, MENSINK RGJ et al. MLH1 and MSH2 protein expression as a prescreening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 2001; 92: 398-403.
5. BOLAND CR, THIBODEAU SN, HAMILTON SR, SIDRANSKY D, ESHLEMAN JR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
6. CAWKWELL L, GRAY S, MURGATROYD H, SUTHERLAND F, HAINE L et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999; 45: 409-415.
7. CAWKWELL L, SUTHERLAND F, MURGATROYD H, JARVIS P, GRAY S et al. Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 2000; 46: 367-369.
8. CHANG DK, RICCIARDIELLO L, GOEL A, CHANG CL, BOLAND CR. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000; 275: 18424-18431.
9. CHARBONNIER F, OLSCHWANG S, WANG Q, BOISSON C, MARTIN C et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62: 848-853.
10. CHAVES P, CRUZ C, LAGE P, CLARO I, CRAVO M et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191: 355-60.
11. CHIARAVALLI AM, FURLAN D, FACCO C, TIBILETTI MG, DIONIGI A et al. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 2001; 438: 39-48.
12. CHRISTENSEN M, KATBALLE N, WIKMAN F, PRIMDAHL H, SORENSEN FB et al. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 2002; 95: 2422-2430.
13. CHUNG DC, RUSTGI AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003; 138: 560-570.
14. CRAVO M, AFONSO AJ, LAG EP, ALBUQUERQUE C, MAIA L et al. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing. Gut 2002; 50: 405-412.
15. CUNNINGHAM JM, CHRISTENSEN ER, TESTER DJ, KIM CY, ROCHE PC et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-3460.
16. CURIA MC, PALMIROTTA R, ACETO G, MESSERINI L, VERI MC et al. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer. Cancer Res 1999; 59: 3570-3575.
17. DEBNIAK T, KURZAWSKI G, GORSKI B, KLADNY J, DOMAGALA W et al. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000; 36: 49-54.
18. DIETMAIER W, WALLINGER S, BOCKER T, KULLMANN F, FISHEL R et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57: 4749-4756.
19. DIEUMEGARD B, GRANDJOUAN S, SABOURIN JC, LE BIHAN ML, LEFRERE I et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000; 82: 871-880.
20. EDMONSTON TB, CUESTA KH, BURKHOLDER S, BARUSEVICIUS A, ROSE D et al. Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 2000; 31: 1506-1514.
21. ERICSON K, HALVARSSON B, NAGEL J, RAMBECH E, PLANCK M et al. Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer. Eur J Cancer 2003; 39: 240-248.
22. ESHLEMAN JR, MARKOWITZ SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996; 5: 1489-1494.
23. FUJIWARA T, STOLKER JM, WATANABE T, RASHID A, LONGO P et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998; 153: 1063-1078.
24. FURUKAWA T, KONISHI F, SHITOH K, KOJIMA M, NAGAI H et al, Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma. Cancer 2002; 94: 911-920.
25. HARTMANN A, CHEVILLE JC, DIETMAIER W, HOFSTÄDTER F, BURGART LJ et al. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med 2003; 127: 60-63.
26. HAWKINS NJ, WARD RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001; 93: 1307-1313.
27. HEMMINKI A, PELTOMÄKI P, MECKLIN JP, JÄRVINEN H, SALOVAARA R et al. Loss of the wild type MLH1 gene is a feature of heretidary nonpolyposis colorectal cancer. Nat Genet 1994; 8: 405-410.
28. HENDRIKS Y, FRANKEN P, DIERSSEN JW, DE LEEUW W, WIJNEN J et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 2003; 162: 469-477.
29. HERMAN JG, UMAR A, POLYAK K, GRAFT JR, AHUJA N et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870-6875.
30. HUANG SC, LAVINE JE, BOLAND PS, NEBURY RK, PHAM TT et al. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001; 138: 629-635.
31. IONO H, SIMMS L, YOUNG J, ARNOLD J, WINSHIP IM et al. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 2000; 47: 37-42.
32. IONOV Y, PEINADO MA, MALKHOSYAN S, SHIBATA D, PERUCHO M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-561.
33. JARVINEN HJ, AARNIO M, MUSTONEN H, AKTAN-COLLAN K, AALTONEN LA et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834.
34. JASS JR. hMLH1 and hMSH2 immunostaining in colorectal cancer. Gut 2000; 47: 315-316.
35. KIM H, PIAO Z, KIM JW, CHOI JS, KIM NK et al. Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract 1998; 194: 3-9.
36. KRUGER S, PLASCHKE J, JESKE B, GORGENS H, PISTORIUS SR et al. Identification of six novel MSH2 and MLH1 germline mutations in HNPCC. Hum Mutat 2003; 21: 445-446.
37. KUISMANEN SA, HOLMBERG MT, SALOVAARA R, DE LA CHAPELLE A, PELTOMAKI P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 2000; 156: 1773-1779.
38. LANZA G, GAFA R, MAESTRI I, SANTINI A, MATTEUZZI M et al. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 2002; 15: 741-749.
39. LEACH FS, POLYAK K, BURRELL M, JOHNSON KA, HILL D et al. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996; 56: 235-240.
40. DE LEEUW WJ, DIERSSEN J, VASEN HF, WIJNEN JT, KENTER GG et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000; 192: 328-335.
41. LINDOR NM, BURGART LJ, LEONTOVICH O, GOLDBERG RM, CUNNINGHAM JM et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-1048.
42. LIU B, NICOLAIDES NC, MARKOWITZ S, WILLSON JKV, PARSONS RE et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9: 48-55.
43. LIU T, TANNERGARD P, HACKMAN P, RUBIO C, KRESSNER U et al. Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet 1999; 105: 437-441.
44. LYNCH HT, DE LA CHAPELLE A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36: 801-818.
45. MARCUS VA, MADLENSKY L, GRYFE R, KIM H, SO K et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248-1255.
46. MULLER W, BURGART LJ, KRAUSE-PAULUS R, THIBODEAU SN, ALMEIDA M et al. ICG-HNPCC (International Collaborative Group). The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer 2001; 1: 87-92.
47. PARAF F, GILQUIN M, LONGY M, GILBERT B, GORRY P et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001; 39: 250-258.
48. PARSONS R, LI GM, LONGLEY MJ, FANG WH, PAPADOPOULOS N et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75: 1227-1236.
49. PELTOMAKI P, VASEN HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113: 1146-1158.
50. PLANCK M, RAMBECH E, MOSLEIN G, MULLER W, OLSSON H et al. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum. Cancer 2002; 94: 2502-2510.
51. PLASCHKE J, KRUGER S, PISTORIUS S, THEISSIG F, SAEGER HD et al. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer 2002; 97: 643-648.
52. RENKONEN E, ZHANG Y, LOHI H, SALOVAARA R, ABDELRAHMAN WM et al. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003; 21: 3629-3637.
53. RIGAU V, SEBBAGH N, OLSCHWANG S, PARAF F, MOURRA N et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 immunostaining. Arch Pathol Lab Med 2003; 127: 694-700.
54. RODRIGUEZ-BIGAS MA, BOLAND CR, HAMILTON SR, HENSON DE, JASS JR et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758-1762.
55. RUSZKIEWICZ A, BENNETT G, MOORE J, MANAVIS J, RUDZKI B et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002; 34: 541-547.
56. SALAHSHOR S, KOELBLE K, RUBIO C, LINDBLOM A. Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 2001; 81: 535-541.
57. SCARTOZZI M, BIANCHI F, ROSATI S, GALIZIA E, ANTOLINI A et al. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002; 20: 1203-1208.
58. SCHWEIZER P, MOISIO AL, KUISMANEN SA, TRUNINGER K, VIERUMÄKI R et al. Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer. Cancer Res 2001; 61: 2813-2815.
59. SOUTHEY MC, YOUNG MA, WHITTY J, MIFSUD S, KEILAR M et al. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis. Am J Surg Pathol 2001; 25: 936-941.
60. STONE JG, ROBERTSON D, HOULSTON RS. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 2001; 54: 484-487.
61. STORMORKEN AT, MULLER W, LEMKEMEYER B, APOLD J, WIJNEN JT et al. Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry. Fam Cancer 2001; 1: 169-173.
62. STRAZZULLO M, COSSU A, BALDINU P, COLOMBINO M, SATTA MP et al. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Cancer 2003; 98: 1540-1546.
63. SYNGAL S, FOX EA, ENG C, KOLODNER RD, GARBER JE. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000; 37: 641-645.
64. TERDIMAN JP, GUM JR JR, CONRAD PG, MILLER GA, WEINBERG V et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 02001; 120: 21-30.
65. THIBODEAU SN, FRENCH AJ, CUNNINGHAM JM, TESTER D, BURGART LJ et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998; 58: 1713-1718.
66. THIBODEAU SN, FRENCH AJ, ROCHE PC, CUNNINGHAM JM, TESTER DJ et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56: 4836-4840.
67. VALENTINI AM, RENNA L, ARMENTANO R, PIRRELLI M, DI LEO A et al. Mismatch repair, p53 and β-catenin proteins in colorectal cancer. Anticancer Res 2002; 22: 2083-2088.
68. VASEN HF, MECKLIN JP, KHAN PM, LYNCH HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
69. VASEN HF, WIJNEN JT, MENKO FH, KLEIBEUKER JH, TAAL BG et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-1027.
70. WAHLBERG S, LIU T, LINDBLOM P, LINDBLOM A. Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test 1999; 3: 259-264.
71. WAHLBERG SS, SCHMEITS J, THOMAS G, LODA M, GARBER J et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002; 62: 3485-3492.
72. WANG Y, FRIEDL W, SENGTELLER M, JUNGCK M, FILGES I et al. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Hum Mutat 2002; 19: 279-286.
73. WARD R, MEAGHER A, TOMLINSON I, O'CONNOR T, NORRIE M et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001; 48: 821-829.
74. WATSON P, LYNCH PT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 677-685.
75. WU Y, BERENDS MJ, MENSINK RG, KEMPINGA C, SIJMONS RH et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999; 65: 1291-1298.
76. WU Y, NYSTROM-LAHTI M, OSINGA J, LOOMAN MW, PELTOMAKI P et al. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 1997; 18: 269-278.
77. WÜLLENWEBER HP, SUTTER C, AUTSCHBACH F, WILEKE F, KIENLE P et al. Evaluation of Bethesda guidelines in relation to microsatellite instability. Dis Colon Rectum 2001; 44: 1281-1289.
78. YOUNG J, SIMMS LA, BIDEN KG, WYNTER C, WHITEHALL V et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001; 159: 2107-2116.